The triglyceride-glucose index is associated with the severity of hepatic steatosis and the presence of liver fibrosis in non-alcoholic fatty liver disease: a cross-sectional study in Chinese adults

被引:69
作者
Guo, Wen [1 ]
Lu, Jing [1 ]
Qin, Pei [1 ]
Li, Xiaona [1 ]
Zhu, Wenfang [1 ]
Wu, Juan [1 ]
Xu, Nianzhen [1 ]
Zhang, Qun [1 ]
机构
[1] Nanjing Med Univ, Dept Hlth Promot Ctr, Affiliated Hosp 1, 300 Guangzhou Rd, Nanjing 210029, Peoples R China
关键词
Triglyceride-glucose index; Hepatic steatosis; Liver fibrosis; Non-alcoholic fatty liver disease; Insulin resistance; HOMA-IR; Predictive value; HOMEOSTASIS MODEL ASSESSMENT; INSULIN-RESISTANCE; MARKERS; MANAGEMENT; RISK; HOMA;
D O I
10.1186/s12944-020-01393-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background The triglyceride-glucose index (TyG) is a reliable predictor of non-alcoholic fatty liver disease (NAFLD). Its association with the severity of hepatic steatosis and liver fibrosis in NAFLD is poorly understood. This study evaluated the relationship between these factors in NAFLD. Methods A total of 4784 participants who underwent ultrasonography were enrolled. Anthropometric and biochemical measurements were assessed. Participants with NAFLD were diagnosed by ultrasound. The degree of hepatic steatosis and liver stiffness was evaluated with transient elastography. Results The TyG index was significantly correlated with the severity of hepatic steatosis and the presence of liver fibrosis in patients with NAFLD. TyG quartile values correlated with increasing prevalence of NAFLD (Q1 30.9%, Q2 53.3%, Q3 71.7%, and Q4 86.4%,P < 0.001) and with the presence of liver fibrosis (Q1 13.5%, Q2 17.6%, Q3 18.8%, and Q4 26.1%,P < 0.001). The AUROC for the TyG index to predict NAFLD was 0.761, resulting in a cut-off value of 8.7. However, the AUC value of the TyG index was 0.589 for liver fibrosis, which was insufficient to predict this condition. The adjusted odds of having hepatic steatosis or liver fibrosis were more strongly associated with TyG values compared with HOMA-IR. Conclusion The TyG index is positively related to the severity of hepatic steatosis and the presence of liver fibrosis in NAFLD. The index also performed better than HOMA-IR.
引用
收藏
页数:9
相关论文
共 32 条
[1]  
Baratta F, 2019, CLIN GASTROENTEROL H
[2]   Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Call to Action [J].
Bril, Fernando ;
Cusi, Kenneth .
DIABETES CARE, 2017, 40 (03) :419-430
[3]   The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD) [J].
Buzzetti, Elena ;
Pinzani, Massimo ;
Tsochatzis, Emmanuel A. .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2016, 65 (08) :1038-1048
[4]   NAFLD as a driver of chronic kidney disease [J].
Byrne, Christopher D. ;
Targher, Giovanni .
JOURNAL OF HEPATOLOGY, 2020, 72 (04) :785-801
[5]   The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases [J].
Chalasani, Naga ;
Younossi, Zobair ;
Lavine, Joel E. ;
Charlton, Michael ;
Cusi, Kenneth ;
Rinella, Mary ;
Harrison, Stephen A. ;
Brunt, Elizabeth M. ;
Sanyal, Arun J. .
HEPATOLOGY, 2018, 67 (01) :328-357
[6]   Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance [J].
Du, Tingting ;
Yuan, Gang ;
Zhang, Muxun ;
Zhou, Xinrong ;
Sun, Xingxing ;
Yu, Xuefeng .
CARDIOVASCULAR DIABETOLOGY, 2014, 13
[7]   Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030 [J].
Estes, Chris ;
Anstee, Quentin M. ;
Teresa Arias-Loste, Maria ;
Bantel, Heike ;
Bellentani, Stefano ;
Caballeria, Joan ;
Colombo, Massimo ;
Craxi, Antonio ;
Crespo, Javier ;
Day, Christopher P. ;
Eguchi, Yuichiro ;
Geier, Andreas ;
Kondili, Loreta A. ;
Kroy, Daniela C. ;
Lazarus, Jeffrey V. ;
Loomba, Rohit ;
Manns, Michael P. ;
Marchesini, Giulio ;
Nakajima, Atsushi ;
Negro, Francesco ;
Petta, Salvatore ;
Ratziu, Vlad ;
Romero-Gomez, Manuel ;
Sanyal, Arun ;
Schattenberg, Joern M. ;
Tacke, Frank ;
Tanaka, Junko ;
Trautwein, Christian ;
Wei, Lai ;
Zeuzem, Stefan ;
Razavi, Homie .
JOURNAL OF HEPATOLOGY, 2018, 69 (04) :896-904
[8]  
Salgado Ana Lúcia Farias de Azevedo, 2010, Arq. Gastroenterol., V47, P165
[9]   HOMA-IR: An independent predictor of advanced liver fibrosis in nondiabetic non-alcoholic fatty liver disease [J].
Fujii, Hideki ;
Imajo, Kento ;
Yoneda, Masato ;
Nakahara, Takashi ;
Hyogo, Hideyuki ;
Takahashi, Hirokazu ;
Hara, Tasuku ;
Tanaka, Saiyu ;
Sumida, Yoshio ;
Eguchi, Yuichiro ;
Chayama, Kazuaki ;
Nakajima, Atsushi ;
Nishimoto, Naoki ;
Kawada, Norifumi .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 (08) :1390-1395
[10]   Markers of insulin resistance and carotid atherosclerosis. A comparison of the homeostasis model assessment and triglyceride glucose index [J].
Irace, C. ;
Carallo, C. ;
Scavelli, F. B. ;
De Franceschi, M. S. ;
Esposito, T. ;
Tripolino, C. ;
Gnasso, A. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2013, 67 (07) :665-672